Systemic immune response to Trichomonas vaginalis infection during pregnancy

Sexually Transmitted Diseases

Volumn 34, Issue 6, 2007, Pages 392-396

  Anderson, Brenna L ^a,b   Cosentino, Lisa A ^a   Simhan, Hyagriv N ^a   Hillier, Sharon L ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; RANTES;

ADULT; ARTICLE; BLOOD SAMPLING; CASE CONTROL STUDY; CELLULAR IMMUNITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; PREGNANCY; PROTEIN BLOOD LEVEL; STANDARD; TRICHOMONAS VAGINALIS; TRICHOMONIASIS; VAGINITIS;

ADULT; ANIMALS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHEMOKINES; CYTOKINES; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; TRICHOMONAS VAGINALIS; TRICHOMONAS VAGINITIS;

EID: 34249340140     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.olq.0000243618.71908.95     Document Type: Article

References (26)

1. Alger LS, Lovchik JC, Hebel JR, et al. The association of Chlamydia trachomatis, Neisseria gonorrhoeae, and group B streptococci with preterm rupture of the membranes and pregnancy outcome. Am J Obstet Gynecol 1988; 159:397-404.
2. Andrews WW, Goldenberg RL, Mercer B, et al. The Preterm Prediction Study: Association of second-trimester genitourinary chlamydia infection with subsequent spontaneous preterm birth. Am J Obstet Gynecol 2000; 183:662-668.
3. Cotch MF, Pastorek JG 2nd, Nugent RP, et al. Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group. Sex Transm Dis 1997; 24:353-360.
4. Klebanoff MA, Carey JC, Hauth JC, et al. Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection. N Engl J Med 2001; 345:487-493.
5. Simhan HN, Anderson BL, Krohn MA, et al. Host immune consequences of asymptomatic Trichomonas vaginalis infection in pregnancy. Am J Obstet Gynecol. In press.
6. Ramsey KH, Schneider H, Cross AS, et al. Inflammatory cytokines produced in response to experimental human gonorrhea. J Infect Dis 1995; 172:186-191.
7. Morrison SG, Morrison RP. In situ analysis of the evolution of the primary immune response in murine Chlamydia trachomatis genital tract infection. Infect Immun 2000; 68:2870-2879.
8. Arntzen KJ, Kjollesdal AM, Halgunset J, et al. TNF, IL-1, IL-6, IL-8 and soluble TNF receptors in relation to chorioamnionitis and premature labor. J Perinat Med 1998; 26:17-26.
9. Hitti J, Hillier SL, Agnew KJ, et al. Vaginal indicators of amniotic fluid infection in preterm labor. Obstet Gynecol 2001; 97:211-219.
10. Hedges SR, Sibley DA, Mayo MS, et al. Cytokine and antibody responses in women infected with Neisseria gonorrhoeae: Effects of concomitant infections. J Infect Dis 1998; 178:742-751.
11. Watts DH, Krohn MA, Hillier SL, et al. Characteristics of women in preterm labor associated with elevated C-reactive protein levels. Obstet Gynecol 1993; 82:509-514.
12. Pitiphat W, Gillman MW, Joshipura KJ, et al. Plasma C-reactive protein in early pregnancy and preterm delivery. Am J Epidemiol 2005; 162:1108-1113.
13. Karinen L, Pouta A, Bloigu A, et al. Serum C-reactive protein and Chlamydia trachomatis antibodies in preterm delivery. Obstet Gynecol 2005; 106:73-80.
14. Porter AE, Auth J, Prince M, et al. Optimization of cytokine stability in stored amniotic fluid. Am J Obstet Gynecol 2001; 185:459-462.
15. de Jager W, te Velthuis H, Prakken BJ, et al. Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells. Clin Diagn Lab Immunol 2003; 10:133-139.
16. Erhardt JG, Estes JE, Pfeiffer CM, et al. Combined measurement of ferritin, soluble transferrin receptor, retinol binding protein, and C-reactive protein by an inexpensive, sensitive, and simple sandwich enzyme-linked immunosorbent assay technique. J Nutr 2004; 134:3127-3132.
17. Torre D, Tambini R, Manfredi M, et al. Circulating levels of granulocyte macrophage colony-stimulating factor in patients with the systemic inflammatory response syndrome. J Infect 2003; 47:296-299.
18. Gray RH, Wabwire-Mangen F, Kigozi G, et al. Randomized trial of presumptive sexually transmitted disease therapy during pregnancy in Rakai, Uganda. Am J Obstet Gynecol 2001; 185:1209-1217.
19. Klein LL, Gibbs RS. Use of microbial cultures and antibiotics in the prevention of infection-associated preterm birth. Am J Obstet Gynecol 2004; 190:1493-1502.
20. Levine WC, Pope V, Bhoomkar A, et al. Increase in endocervical CD4 lymphocytes among women with nonulcerative sexually transmitted diseases. J Infect Dis 1998; 177:167-174.
21. Gilbert RO, Elia G, Beach DH, et al. Cytopathogenic effect of Trichomonas vaginalis on human vaginal epithelial cells cultured in vitro. Infect Immun 2000; 68:4200-4206.
22. Miller W, Swygard H, Hobbs M, et al. The prevalence of trichomoniasis in young adults in the United States. Sex Transm Dis 2005; 32:593-598.
23. Sorvillo F, Smith L, Kerndt P, et al. Trichomonas vaginalis, HIV, and African-Americans. Emerg Infect Dis 2001; 7:927-932.
24. Price MA, Zimba Da, Hoffman IF, et al. Addition of treatment for trichomoniasis to syndromic management of urethritis in Malawi: A randomized clinical trial. Sex Transm Dis 2003; 30:516-522.
25. Van Der Pol B, Williams JA, Orr DP, et al. Prevalence, incidence, natural history, and response to treatment of Trichomonas vaginalis infection among adolescent women. J Infect Dis 2005; 192:2039-2044.
26. Patton D, Agnew K, Hillier SL. Abstracts of the Annual Scientific Meeting and Symposium/macaque model for Trichomonas vaginalis infection. Infect Dis Obstet Gynecol 2005; 13:103.